Aquestive Therapeutics, Inc. (AQST) Stock Grade

About Aquestive Therapeutics, Inc.'s fundamentals

Aquestive Therapeutics is a specialty pharmaceutical company with a market capitalization of $596.0 million that reported significant financial challenges in its latest annual results. The company experienced a 22.6% year-over-year decline in revenue and posted a net loss, resulting in a negative net margin of -188.1%. With no dividend yield and an absence of a meaningful P/E ratio due to unprofitability, the company's financial metrics reflect a loss-making operational status typical of pharmaceutical firms in development or turnaround phases.